Trefoil Therapeutics

Perfuse Therapeutics

The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.

EyeYon

This company develops synthetic corneal implants and therapeutic contact lenses for patients with corneal diseases, providing alternatives to traditional donor tissue transplants.

Eyexora

This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.

StemSight

This company develops stem cell therapies using biomaterials to treat corneal blindness in patients with limbal stem cell deficiency and other eye conditions.

Healome Therapeutics

The company develops eye-drop matrix technology to improve drug delivery and treatment for patients with ocular surface diseases.

Tavo Biotherapeutics

The company develops topical and injectable treatments for patients with glaucoma and retinal diseases.

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.

Amber Ophthalmics

The company develops biopharmaceutical therapies to treat rare anterior segment eye diseases such as persistent corneal epithelial defects for patients.